"Where will we be in ten years from now? I think the next leap is greater than the last one. Science and technology growth is exponential, last but not least also through our small contribution in intelligent semantic software development. I expect systems that can answer more complex questions in biomedicine through the integration of text and data mining. Today our systems mostly rely on text analysis since structured data is only partly available. But the trend is set: data are the base for the written publication and give valuable insight and allow to draw conclusions in much better ways. An exciting road to go!" so Dr. Michael R. Alvers, CEO of Transinsight.
"Congratulations to our team! Thanks for excellent work over the past ten years. Thanks to all our valued customers for believing in a small startup in the early years of semantics. You made it possible! Let’s move on," concluded Dr. Alvers.
About Transinsight
Transinsight develops knowledge-based solutions. Their semantic software platform Enterprise Semantic Intelligence® powers the knowledge-based search systems www.Go3R.org and www.GoPubMed.com, semantic search engines for the next generation. In acknowledgement of the technologies developed by the company, Transinsight has repeatedly been honored with international awards amongst others the reddot design award - communication design - best of the best 2009, the German Industry Prize 2010, the German Innovation Prize IT 2011 and the Detecon ICT Award 2012. The firm works in close collaboration with the Dresden University of Technology. Selected customers are: Unilever, BASF, Adipogen, Abcam und Bayer. Internet: www.transinsight.com.